Making A DifferenceSeven Months Post Infection, SARS-CoV-2 Antibody Immunoglobulin G Either Remains Stable Or Increases: StudyBY Outlook Web Desk
Making A DifferenceDrug Used To Reduce Blood Fat Is Capable Of Cutting Down SARS-CoV-2 Infection By 70 Per Cent: StudyBY Outlook Web Desk
Making A DifferenceResearchers Develop Variants Of More Potent, Stable Nanobodies To Fight SARS-CoV-2BY Outlook Web Desk
NationalPhase Three Clinical Trial Concludes 77.8 Per Cent Effectiveness Of CovaxinBY Outlook Web Desk
Making A DifferenceFirst Covid-19 Case Could Have Emerged in China in October 2019, Reveals StudyBY Outlook Web Bureau
.jpg?auto=format%2Ccompress&fit=max&format=webp&w=300&dpr=1.0)
.jpg?auto=format%2Ccompress&fit=max&format=webp&w=300&dpr=1.0)